Literature DB >> 16420578

ERK2 activation in arteriolar and venular murine thrombosis: platelet receptor GPIb vs. P2X.

C Oury1, K Daenens, H Hu, E Toth-Zsamboki, M Bryckaert, M F Hoylaerts.   

Abstract

The functional significance of extracellular signal-regulated kinase 2 (ERK2) activation was investigated during shear induced human platelet aggregation (SIPA) in vitro and during shear controlled thrombosis in vivo in intestinal arterioles and venules of wild type (WT) and transgenic (TG) mice with platelet-specific overexpression of human P2X(1) (TG). In SIPA, ERK2 was rapidly phosphorylated during GPIb stimulation, its activation contributing to SIPA for 50%, independently of P2X(1) regulation. Thrombotic occlusion of injured arterioles occurred considerably faster in TG (4.3 +/- 2.3 min) than in WT (38 +/- 8 min) arterioles, but occlusion times in TG (19 +/- 12) and WT (48 +/- 4.5 min) venules differed less. Both the alphabeta-meATP triggered desensitization of platelet P2X(1), as well as P2X(1) antagonism by NF279 or NF449 prolonged mean occlusion to about 75 min in WT and 65 min in TG arterioles, but venular occlusion times were less affected. Preventing ERK2 activation by U0126 prolonged occlusion times in TG (41 +/- 10 min) and WT (51 +/- 17) arterioles more than in TG (46 +/- 5 min) and WT (56 +/- 6 min) venules, uncovering a role for ERK2 in shear controlled thrombosis. Antagonism of GPIb by a recombinant murine von Willebrand factor (VWF)-A1 fragment prolonged occlusion times to comparable values, ranging from 55 to 58 min, both in TG and WT arterioles and venules. Further inhibition strategies, combining VWF-A1, U0126 and NF449 in WT and TG mice and resulting in occlusion in various time windows, identified that inhibition by VWF-A1 largely abrogated the ERK2 contribution to thrombosis. In conclusion, P2X(1) and ERK2 both participate in shear stress controlled thrombosis, but ERK2 activation is initiated predominantly via GPIb-VWF interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16420578     DOI: 10.1111/j.1538-7836.2006.01745.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice.

Authors:  Roxane Darbousset; Céline Delierneux; Soraya Mezouar; Alexandre Hego; Christelle Lecut; Isabelle Guillaumat; Markus A Riederer; Richard J Evans; Françoise Dignat-George; Laurence Panicot-Dubois; Cécile Oury; Christophe Dubois
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

2.  Stressed platelets ASK1 for a MAPK.

Authors:  Robert Flaumenhaft
Journal:  Blood       Date:  2017-03-02       Impact factor: 22.113

3.  Ask1 regulates murine platelet granule secretion, thromboxane A2 generation, and thrombus formation.

Authors:  Meghna U Naik; Pravin Patel; Randall Derstine; Ramya Turaga; Xi Chen; Kalyan Golla; Keith B Neeves; Hidenori Ichijo; Ulhas P Naik
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

Review 4.  The P2X1 receptor as a therapeutic target.

Authors:  Felix M Bennetts; Jesse I Mobbs; Sabatino Ventura; David M Thal
Journal:  Purinergic Signal       Date:  2022-07-11       Impact factor: 3.950

5.  Platelet Ca(2+) responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca(2+) stores.

Authors:  C Y Eleanor Fung; Sarah Jones; Adwoa Ntrakwah; Khalid M Naseem; Richard W Farndale; Martyn P Mahaut-Smith
Journal:  Blood       Date:  2012-01-06       Impact factor: 22.113

6.  The P2X1 receptor and platelet function.

Authors:  Martyn P Mahaut-Smith; Sarah Jones; Richard J Evans
Journal:  Purinergic Signal       Date:  2011-03-22       Impact factor: 3.765

Review 7.  Purinergic control of inflammation and thrombosis: Role of P2X1 receptors.

Authors:  Cécile Oury; Christelle Lecut; Alexandre Hego; Odile Wéra; Céline Delierneux
Journal:  Comput Struct Biotechnol J       Date:  2014-11-28       Impact factor: 7.271

Review 8.  Of von Willebrand factor and platelets.

Authors:  Marijke Bryckaert; Jean-Philippe Rosa; Cécile V Denis; Peter J Lenting
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.